Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Rehabilitation Outcomes of Patients With Severe Disability Poststroke.

Scrutinio D, Guida P, Lanzillo B, Ferretti C, Loverre A, Montrone N, Spaccavento S.

Arch Phys Med Rehabil. 2019 Mar;100(3):520-529.e3. doi: 10.1016/j.apmr.2018.06.023. Epub 2018 Jul 26.

PMID:
30056158
2.

Effect of subtypes of neglect on functional outcome in stroke patients.

Spaccavento S, Cellamare F, Falcone R, Loverre A, Nardulli R.

Ann Phys Rehabil Med. 2017 Nov;60(6):376-381. doi: 10.1016/j.rehab.2017.07.245. Epub 2017 Sep 22.

3.

Italian adaptation of the functional outcome questionnaire - aphasia: initial psychometric evaluation.

Spaccavento S, Cafforio E, Cellamare F, Colucci A, Di Palma A, Falcone R, Craca A, Loverre A, Nardulli R, Glueckauf RL.

Disabil Rehabil. 2018 Dec;40(24):2925-2930. doi: 10.1080/09638288.2017.1362042. Epub 2017 Aug 4.

PMID:
28776480
4.

Efficacy of visual-scanning training and prism adaptation for neglect rehabilitation.

Spaccavento S, Cellamare F, Cafforio E, Loverre A, Craca A.

Appl Neuropsychol Adult. 2016 Sep-Oct;23(5):313-21. doi: 10.1080/23279095.2015.1038386. Epub 2015 Nov 19.

PMID:
26583597
5.

Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.

Simone S, Loverre A, Cariello M, Divella C, Castellano G, Gesualdo L, Pertosa G, Grandaliano G.

J Nephrol. 2014 Oct;27(5):555-62. doi: 10.1007/s40620-014-0050-7. Epub 2014 Feb 27.

PMID:
24574138
6.

Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.

Curci C, Castellano G, Stasi A, Divella C, Loverre A, Gigante M, Simone S, Cariello M, Montinaro V, Lucarelli G, Ditonno P, Battaglia M, Crovace A, Staffieri F, Oortwijn B, van Amersfoort E, Gesualdo L, Grandaliano G.

Nephrol Dial Transplant. 2014 Apr;29(4):799-808. doi: 10.1093/ndt/gft516. Epub 2014 Jan 23.

PMID:
24463188
7.

Quality of life measurement and outcome in aphasia.

Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A.

Neuropsychiatr Dis Treat. 2014;10:27-37. doi: 10.2147/NDT.S52357. Epub 2013 Dec 17.

8.

A case of atypical progressive supranuclear palsy.

Spaccavento S, Del Prete M, Craca A, Loverre A.

Clin Interv Aging. 2014;9:31-9. doi: 10.2147/CIA.S51640. Epub 2013 Dec 16.

9.

Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin.

Sallustio F, Costantino V, Cox SN, Loverre A, Divella C, Rizzi M, Schena FP.

Kidney Int. 2013 Mar;83(3):392-403. doi: 10.1038/ki.2012.413. Epub 2013 Jan 16. Retraction in: Kidney Int. 2015 Feb;87(2):482.

10.

Multiple system atrophy with early cognitive deficits: a case report.

Spaccavento S, Del Prete M, Loverre A, Craca A, Nardulli R.

Neurocase. 2013;19(6):613-22. doi: 10.1080/13554794.2012.713494. Epub 2012 Sep 17.

PMID:
22978465
11.

Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy.

Cox SN, Sallustio F, Serino G, Loverre A, Pesce F, Gigante M, Zaza G, Stifanelli PF, Ancona N, Schena FP.

Kidney Int. 2012 Sep;82(5):548-60. doi: 10.1038/ki.2012.147. Epub 2012 May 9.

12.

BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation.

Simone S, Cosola C, Loverre A, Cariello M, Sallustio F, Rascio F, Gesualdo L, Schena FP, Grandaliano G, Pertosa G.

Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F23-34. doi: 10.1152/ajprenal.00328.2011. Epub 2012 Apr 11.

13.

Regulation of TGF-β1 expression by androgen deprivation therapy of prostate cancer.

Fuzio P, Ditonno P, Rutigliano M, Battaglia M, Bettocchi C, Loverre A, Grandaliano G, Perlino E.

Cancer Lett. 2012 May 28;318(2):135-44. doi: 10.1016/j.canlet.2011.08.034. Epub 2011 Oct 1.

PMID:
22269108
14.

Coagulation activation is associated with nicotinamide adenine dinucleotide phosphate oxidase-dependent reactive oxygen species generation in hemodialysis patients.

Cariello M, Simone S, Loverre A, Gigante M, Incampo F, Pietanza S, Colucci M, Schena FP, Gesualdo L, Grandaliano G, Pertosa G.

Antioxid Redox Signal. 2012 Mar 1;16(5):428-39. doi: 10.1089/ars.2011.4062. Epub 2011 Dec 22.

PMID:
22191478
15.

IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection.

Loverre A, Tataranni T, Castellano G, Divella C, Battaglia M, Ditonno P, Corcelli M, Mangino M, Gesualdo L, Schena FP, Grandaliano G.

Am J Transplant. 2011 Jun;11(6):1248-59. doi: 10.1111/j.1600-6143.2011.03529.x.

16.

Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins.

Stallone G, Infante B, Pontrelli P, Gigante M, Montemurno E, Loverre A, Rossini M, Schena FP, Grandaliano G, Gesualdo L.

Transplantation. 2011 May 15;91(9):997-1004. doi: 10.1097/TP.0b013e318211d342.

PMID:
21364499
17.

The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis.

De Palma G, Castellano G, Del Prete A, Sozzani S, Fiore N, Loverre A, Parmentier M, Gesualdo L, Grandaliano G, Schena FP.

Kidney Int. 2011 Jun;79(11):1228-35. doi: 10.1038/ki.2011.32. Epub 2011 Feb 23.

18.

T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function.

Loverre A, Divella C, Castellano G, Tataranni T, Zaza G, Rossini M, Ditonno P, Battaglia M, Palazzo S, Gigante M, Ranieri E, Schena FP, Grandaliano G.

Transpl Int. 2011 Mar;24(3):233-42. doi: 10.1111/j.1432-2277.2010.01157.x. Epub 2010 Sep 7.

19.

Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction.

Divella C, Rossini M, Loverre A, Schena A, Maiorano A, Gesualdo V, Zaza G, Grandaliano G, Schena FP.

Nephrol Dial Transplant. 2010 Dec;25(12):4071-7. doi: 10.1093/ndt/gfq377. Epub 2010 Jun 30.

PMID:
20595199
20.

Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

Castellano G, Melchiorre R, Loverre A, Ditonno P, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van Wetering S, Paolo Schena F, Grandaliano G.

Am J Pathol. 2010 Apr;176(4):1648-59. doi: 10.2353/ajpath.2010.090276. Epub 2010 Feb 11.

21.

TLR2 plays a role in the activation of human resident renal stem/progenitor cells.

Sallustio F, De Benedictis L, Castellano G, Zaza G, Loverre A, Costantino V, Grandaliano G, Schena FP.

FASEB J. 2010 Feb;24(2):514-25. doi: 10.1096/fj.09-136481. Epub 2009 Oct 20.

PMID:
19843711
22.

Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula.

Castellano G, Di Vittorio A, Dalfino G, Loverre A, Marrone D, Simone S, Schena FP, Pertosa G, Grandaliano G.

Atherosclerosis. 2010 Mar;209(1):241-7. doi: 10.1016/j.atherosclerosis.2009.08.044. Epub 2009 Aug 31.

PMID:
19772962
23.

Activation of PI3-kinase/Akt induced small bowel cell apoptosis during laparoscopic ischaemia-reperfusion of swine jejunum.

Puglisi F, Lacitigniola L, Loverre A, Capuano P, Martines G, Staffieri F, Rossi G, Crovace A.

Acta Chir Belg. 2009 Mar-Apr;109(2):216-23.

PMID:
19499684
24.

ID2-VEGF-related pathways in the pathogenesis of Kaposi's sarcoma: a link disrupted by rapamycin.

Stallone G, Infante B, Pontrelli P, Ranieri E, Loverre A, Schena A, Cormio L, Carrieri G, Schena FP, Grandaliano G, Gesualdo L.

Am J Transplant. 2009 Mar;9(3):558-66. doi: 10.1111/j.1600-6143.2008.02537.x.

25.

Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.

Gigante M, Blasi A, Loverre A, Mancini V, Battaglia M, Selvaggi FP, Maiorano E, Napoli A, Castellano G, Storkus WJ, Gesualdo L, Ranieri E.

Mol Immunol. 2009 Feb;46(5):893-901. doi: 10.1016/j.molimm.2008.09.015. Epub 2008 Nov 28.

26.

Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function.

Loverre A, Capobianco C, Ditonno P, Battaglia M, Grandaliano G, Schena FP.

Transplantation. 2008 Apr 27;85(8):1112-9. doi: 10.1097/TP.0b013e31816a8891.

PMID:
18431230
27.

Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.

Pontrelli P, Rossini M, Infante B, Stallone G, Schena A, Loverre A, Ursi M, Verrienti R, Maiorano A, Zaza G, Ranieri E, Gesualdo L, Ditonno P, Bettocchi C, Schena FP, Grandaliano G.

Transplantation. 2008 Jan 15;85(1):125-34. doi: 10.1097/01.tp.0000296831.91303.9a.

PMID:
18192922
28.

Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function.

Loverre A, Capobianco C, Stallone G, Infante B, Schena A, Ditonno P, Palazzo S, Battaglia M, Crovace A, Castellano G, Ranieri E, Schena FP, Gesualdo L, Grandaliano G.

Kidney Int. 2007 Oct;72(8):994-1003. Epub 2007 Aug 8.

29.

Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis.

Fiore N, Castellano G, Blasi A, Capobianco C, Loverre A, Montinaro V, Netti S, Torres D, Manno C, Grandaliano G, Ranieri E, Schena FP, Gesualdo L.

Mol Immunol. 2008 Jan;45(1):259-65. Epub 2007 Jun 13.

PMID:
17570528
30.

Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients.

Marrone D, Pertosa G, Simone S, Loverre A, Capobianco C, Cifarelli M, Memoli B, Schena FP, Grandaliano G.

Am J Kidney Dis. 2007 May;49(5):664-73.

PMID:
17472849
31.

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.

Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G.

J Am Soc Nephrol. 2005 Dec;16(12):3755-62. Epub 2005 Oct 19.

32.

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G.

N Engl J Med. 2005 Mar 31;352(13):1317-23.

33.

Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.

Loverre A, Ditonno P, Crovace A, Gesualdo L, Ranieri E, Pontrelli P, Stallone G, Infante B, Schena A, Di Paolo S, Capobianco C, Ursi M, Palazzo S, Battaglia M, Selvaggi FP, Schena FP, Grandaliano G.

J Am Soc Nephrol. 2004 Oct;15(10):2675-86.

34.

Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.

Grandaliano G, Pontrelli P, Cerullo G, Monno R, Ranieri E, Ursi M, Loverre A, Gesualdo L, Schena FP.

J Am Soc Nephrol. 2003 Aug;14(8):2072-83.

35.

CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor.

Trabace L, Cassano T, Loverre A, Steardo L, Cuomo V.

CNS Drug Rev. 2002 Spring;8(1):53-69. Review.

36.

Analysis of an SD second chromosome from a natural population of Drosophila melanogaster.

Cicchetti R, Loverre A.

Genetica. 1988-1989;78(3):159-67.

PMID:
3152053
37.

Is the segregation distortion phenomenon in Drosophila due to recurrent active genetic transposition?

Hickey DA, Loverre A, Carmody G.

Genetics. 1986 Oct;114(2):665-8. No abstract available.

38.

Biological parameters and the segregation distortion (SD) phenomenon in Drosophila melanogaster.

Trippa G, Cicchetti R, Loverre A, Micheli A.

Genetics. 1981 Mar-Apr;97(3-4):563-80.

39.
40.

Thermostability studies for investigating non-electrophoretic polymorphic alleles in Drosophila melanogaster.

Trippa G, Loverre A, Catamo A.

Nature. 1976 Mar 4;260(5546):42-4. No abstract available.

PMID:
817203
41.

Supplemental Content

Loading ...
Support Center